X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211461
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205173
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210342
https://www.fiercepharma.com/pharma-asia/foreign-drugmakers-under-threat-as-china-rolls-out-drug-list-to-boost-generic
https://www.moneycontrol.com/news/business/stocks/lupin-gains-as-co-receives-usfda-approval-for-bosentan-tablets-3921051.html
https://www.moneycontrol.com/news/business/lupin-natco-get-usfda-nod-to-market-generic-hypertension-drug-3916061.html
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-tracleer-209279-bosentan-for-oral-suspension-1554959700.pdf
https://www.reuters.com/article/us-johnson-johnson-settlement/jj-unit-to-pay-360-million-to-u-s-to-resolve-charity-kickback-probe-idUSKBN1O51XB
http://www.pmlive.com/pharma_news/fda_names_and_shames_generic-blocking_pharma_companies_1235934
http://www.biospace.com/News/exec-reveals-sanofi-is-hunting-for-mas-to-boost/453151/source=TopBreaking?intcid=homepage-seekernewssection-tabtopbreakingnews
http://www.fiercepharma.com/pharma/actelion-fails-key-phase-3-but-investors-brush-it-off-as-j-j-mega-deal-draws-near
http://www.bloomberg.com/news/articles/2016-04-21/actelion-chief-says-no-suitors-are-courting-drugmaker-with-deals
http://www.fiercepharma.com/story/potential-restrict-generics-rems-growing-and-does-not-bode-well-biosimilars/2016-03-07
http://www.reuters.com/article/us-actelion-results-idUSKCN0VI0BF
http://www.reuters.com/article/us-actelion-pah-prices-idUSKBN0UJ1SQ20160105
http://www.fiercepharma.com/story/fda-nod-actelion-adds-blockbuster-hopeful-uptravi-pah-portfolio/2015-12-22
http://www.reuters.com/article/us-actelion-fda-idUSKBN0U50HO20151222
http://www.business-standard.com/article/opinion/natco-pharma-seeks-next-level-of-growth-115092300990_1.html
http://www.fiercebiotech.com/story/zs-pharma-rockets-word-25b-offer-actelion/2015-09-10
http://www.pmlive.com/pharma_news/gilead_and_gsk_pulmonary_hypertension_drugs_work_in_tandem_807320?utm_content=buffer11e7f&utm_medium=social&utm_source=twitter.com&utm_campaign=buffer
http://www.fiercepharmaasia.com/story/japans-pafsc-review-application-takeda-glatiramer-week/2015-08-26
http://www.fiercepharma.com/story/actelions-opsumit-growth-heralds-smooth-switch-aging-tracleer/2015-07-21
http://www.fiercevaccines.com/story/actelion-pours-out-33m-create-vaccine-startup-max-planck-society/2015-07-01
http://www.fiercebiotech.com/story/actelion-creates-vaccine-startup-30m-investment-and-max-planck-assets/2015-06-30
http://www.pharmatimes.com/Article/15-04-16/Actelion_moves_MS_pill_into_PhIII.aspx
http://blogs.wsj.com/pharmalot/2015/01/23/ema-recommends-hundreds-of-drugs-to-be-suspended-over-flawed-studies/
Market Place
Share 
